Actions of SPM in regulating host responses in arthritis
- 1 December 2017
- journal article
- review article
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 58, 57-64
Abstract
No abstract availableKeywords
Funding Information
- Arthritis Research UK (19909)
- Medical Research Council UK (MR/K013068/1)
- Wellcome Trust (086867)
- National Institutes of Health Research
This publication has 95 references indexed in Scilit:
- Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic InflammationThe Journal of Immunology, 2016
- Specialised pro-resolving mediators of inflammation in inflammatory arthritisProstaglandins, Leukotrienes and Essential Fatty Acids, 2016
- 17(R)‐resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociceptionBritish Journal of Pharmacology, 2011
- 5-Lipoxygenase–Deficient Mice Infected with Borrelia burgdorferi Develop Persistent ArthritisThe Journal of Immunology, 2011
- Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti‐nociceptionBritish Journal of Pharmacology, 2010
- Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on ‘Nutrition and autoimmune disease’ PUFA, inflammatory processes and rheumatoid arthritisProceedings of the Nutrition Society, 2008
- Augmentation of Myocardial Production of 15-Epi-Lipoxin-A 4 by Pioglitazone and Atorvastatin in the RatCirculation, 2006
- Epidemiology and Risk Factors of Periodontal DiseasesDental Clinics of North America, 2005
- Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1Journal of Experimental Medicine, 2005
- Nails in the coffin: Increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritisArthritis & Rheumatism, 2001